http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114276345-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate | 2021-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-114276345-B |
| titleOfInvention | 3-(Azidomethyl)-1,3-dimethyl-1,8-naphthyridine-2,4(1H,3H)-dione |
| abstract | The invention belongs to the field of pharmacy, and specifically relates to 3-(azidomethyl)-1,3-dimethyl-1,8-naphthyridine-2,4(1H,3H)-dione compounds and applications thereof. The compound of the present invention is prepared by metal-free catalyzed free radical tandem carbocyclization reaction, and is a yellow solid with a molecular formula of C 11 H 11 N 5 O 4 . Studies have shown that the compound can be used in the preparation of anti-tumor and other drugs. |
| priorityDate | 2021-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 48.